Phase 2 study of TG4001 shows promise in cervical cancer patients
News
Heart patient goes home hours after live-streamed valve replacement
Sheffield cardiologists demonstrate cutting-edge TAVI procedure
Johnson & Johnson myeloma drug recommended for NHS use
Teclistamab offers hope for patients exhausting treatment options
Purespring Therapeutics secures £80 million in Series B funding
New investment to advance gene therapies for kidney diseases
Sanofi launches high-dose flu vaccine in the UK
New vaccine aims to protect older adults from severe flu complications
Kyowa Kirin announces positive interim data for lymphoma treatment
Real-world studies show effectiveness of mogamulizumab in routine practice
Astellas and AviadoBio announce exclusive gene therapy deal
AviadoBio to receive up to £1.8 billion in potential payments
FluoGuide submits clinical trial application for head and neck cancer treatment
Biotech company moves forward with phase 2 trial for precision cancer surgery
Scottish patients first in UK to access new lung cancer treatment
Scottish Medicines Consortium recommends pembrolizumab
IRLAB’s new drug shows promise in treating apathy in Parkinson’s patients
Phase 1 trial of IRL757 demonstrates good absorption and safety profile
ERLEADA shows 23% survival benefit over enzalutamide in prostate cancer study
Largest real-world study demonstrates significant survival advantage
Insilico Medicine reports positive results for idiopathic pulmonary fibrosis therapy
ISM001-055 shows promise in improving lung function among patients
AlzeCure’s ACD856’s effects to be presented at Alzheimer’s conference
Preclinical data on NeuroRestore therapy to be showcased at CTAD in Madrid
EC approves Yuvanci for pulmonary arterial hypertension treatment
Janssen-Cilag therapy becomes the first single tablet combination therapy for PAH in europe
Sheffield A&E to implement life-saving HIV and hepatitis testing
New government scheme to offer routine opt-out blood tests
